Select for export Spatiotemporal brain dynamics of emotional face processing modulations induced by the serotonin 1A/2A receptor agonist psilocybin. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/cercor/bht178 PubMed 23861318 Copy citation Copy BibTeX Cerebral Cortex 2013-07-15 Bernasconi F, Schmidt A, Pokorny T, Kometer M, Seifritz E, Vollenweider FX. Europe PMC Published psilocybin Brain ImagingMechanism of ActionReceptor Pharmacology Observational Study More
Select for export Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.biopsych.2012.04.005 PubMed 22578254 Copy citation Copy BibTeX Biological Psychiatry 2012-05-09 Kometer M, Schmidt A, Bachmann R, Studerus E, Seifritz E, Vollenweider FX. Europe PMC Published psilocybin DepressionMechanism of ActionReceptor Pharmacology Clinical Trial More
Select for export Mismatch negativity encoding of prediction errors predicts S-ketamine-induced cognitive impairments. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/npp.2011.261 PubMed 22030715 Copy citation Copy BibTeX Unknown journal 2011-10-25 Schmidt A, Bachmann R, Kometer M, Csomor PA, Stephan KE, Seifritz E Europe PMC Published psilocybin Mechanism of ActionReceptor PharmacologyConsciousness Other More
Select for export The neurobiology of psychedelic drugs: implications for the treatment of mood disorders. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/nrn2884 PubMed 20717121 Copy citation Copy BibTeX Unknown journal 2010-08-17 Vollenweider FX, Kometer M. Europe PMC Published psilocybin NeuroplasticityBrain ImagingMechanism of Action Other More
Select for export Modulating the rate and rhythmicity of perceptual rivalry alternations with the mixed 5-HT2A and 5-HT1A agonist psilocybin. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/sj.npp.1300621 PubMed 15688092 Copy citation Copy BibTeX Unknown journal 2005-05-31 Carter OL, Pettigrew JD, Hasler F, Wallis GM, Liu GB, Hell D Europe PMC Published psilocybin PharmacologyMechanism of ActionReceptor Pharmacology Clinical Trial More
Select for export Brain mechanisms of hallucinogens and entactogens. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.31887/dcns.2001.3.4/fxvollenweider PubMed 22033605 Copy citation Copy BibTeX Unknown journal 2001-11-30 Vollenweider FX. Europe PMC Published psilocybin Brain ImagingMechanism of ActionReceptor Pharmacology Review Article More
Select for export A systems model of altered consciousness: integrating natural and drug-induced psychoses. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/s0361-9230(01)00646-3 PubMed 11750795 Copy citation Copy BibTeX Unknown journal 2001-10-31 Vollenweider FX, Geyer MA. Europe PMC Published psilocybin Brain ImagingMechanism of ActionReceptor Pharmacology Other More
